GUD:TSE
Knight Therapeutics Inc
CA$10.61
arrow_downward
-0.66%(-0.070) 1D
Oct 14, 4:00:01 PM GMT-4 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUD...
Open
CA$10.65
High
CA$10.73
Low
CA$10.59
Mkt. cap
1.04B
Avg. vol.
83.58K
Volume
67.01K
P/E ratio
70.74
52-wk high
CA$11.00
52-wk low
CA$5.66
EPS
CA$0.15
Beta
-0.07
Shares outstanding
98.23M
No. of employees
830
Open
CA$10.65
High
CA$10.73
Low
CA$10.59
Mkt. cap
1.04B
Avg. vol.
83.58K
Volume
67.01K
P/E ratio
70.74
52-wk high
CA$11.00
52-wk low
CA$5.66
EPS
CA$0.15
Beta
-0.07
Shares outstanding
98.23M
No. of employees
830
News stories
From web sources and news partners
Barron's
·
15 minutes ago
The S&P 500’s Dividend Yield Is at an All-Time Low. Is That a Bad Sign?
Yahoo Finance
·
50 minutes ago
Nasdaq futures dive 1% as AI rout deepens on debt concerns
Seeking Alpha
·
40 minutes ago
Tech sector breaks uptrend, raising risk of further S&P 500 losses (XLK:NYSEARCA)
Investor's Business Daily
·
5 hours ago
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersMontreal, Quebec, Canada
SectorPharmaceutical industry
Websiteknighttx.com